RS51056B - Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičkih poremećaja - Google Patents

Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičkih poremećaja

Info

Publication number
RS51056B
RS51056B YUP-675/03A YUP67503A RS51056B RS 51056 B RS51056 B RS 51056B YU P67503 A YUP67503 A YU P67503A RS 51056 B RS51056 B RS 51056B
Authority
RS
Serbia
Prior art keywords
formula
group
phenyl
alkyl
psychotic disorders
Prior art date
Application number
YUP-675/03A
Other languages
English (en)
Serbian (sr)
Inventor
Carlos R. Plata-Salaman
Boyu Zhao
Roy E. Twyman
Original Assignee
Ortho-Mcneil Pharmaceutical Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical Inc. filed Critical Ortho-Mcneil Pharmaceutical Inc.
Publication of RS67503A publication Critical patent/RS67503A/sr
Publication of RS51056B publication Critical patent/RS51056B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YUP-675/03A 2001-02-27 2002-02-21 Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičkih poremećaja RS51056B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
RS67503A RS67503A (sr) 2006-12-15
RS51056B true RS51056B (sr) 2010-10-31

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-675/03A RS51056B (sr) 2001-02-27 2002-02-21 Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičkih poremećaja

Country Status (25)

Country Link
US (1) US6541513B2 (enExample)
EP (1) EP1401424B1 (enExample)
JP (1) JP4276841B2 (enExample)
KR (1) KR100886578B1 (enExample)
CN (1) CN1262271C (enExample)
AR (1) AR032876A1 (enExample)
AT (1) ATE346597T1 (enExample)
AU (1) AU2002242296B2 (enExample)
BR (1) BR0207829A (enExample)
CA (1) CA2439480C (enExample)
CZ (1) CZ302412B6 (enExample)
DE (1) DE60216457T2 (enExample)
DK (1) DK1401424T3 (enExample)
ES (1) ES2275844T3 (enExample)
HU (1) HUP0303342A3 (enExample)
IL (2) IL157588A0 (enExample)
MX (1) MXPA03007722A (enExample)
NO (1) NO20033801L (enExample)
NZ (1) NZ527991A (enExample)
PL (1) PL365021A1 (enExample)
PT (1) PT1401424E (enExample)
RS (1) RS51056B (enExample)
RU (1) RU2302240C2 (enExample)
TW (1) TWI251486B (enExample)
WO (1) WO2002067927A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2002067925A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
CA2439286A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
DE60232796D1 (de) 2001-07-16 2009-08-13 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
WO2008054984A1 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9907776B2 (en) 2013-03-12 2018-03-06 Bio-Pharm Solutions, Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
JP2955358B2 (ja) * 1989-06-09 1999-10-04 ファルマシア・アンド・アップジョン・カンパニー 中枢神経系活性を有する複素環系アミン
US5492930A (en) 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
RU2003128983A (ru) 2005-03-10
EP1401424A1 (en) 2004-03-31
IL157588A0 (en) 2004-03-28
CA2439480A1 (en) 2002-09-06
AU2002242296B2 (en) 2006-06-29
CZ302412B6 (cs) 2011-05-04
WO2002067927A1 (en) 2002-09-06
NO20033801D0 (no) 2003-08-26
JP4276841B2 (ja) 2009-06-10
AR032876A1 (es) 2003-11-26
DE60216457T2 (de) 2007-09-20
NZ527991A (en) 2005-04-29
EP1401424B1 (en) 2006-11-29
ES2275844T3 (es) 2007-06-16
PT1401424E (pt) 2007-02-28
JP2004523556A (ja) 2004-08-05
DE60216457D1 (de) 2007-01-11
HUP0303342A3 (en) 2012-07-30
NO20033801L (no) 2003-10-22
CN1505507A (zh) 2004-06-16
KR100886578B1 (ko) 2009-03-05
KR20030076713A (ko) 2003-09-26
ATE346597T1 (de) 2006-12-15
RU2302240C2 (ru) 2007-07-10
PL365021A1 (en) 2004-12-27
CN1262271C (zh) 2006-07-05
IL157588A (en) 2009-12-24
HUP0303342A2 (hu) 2004-01-28
TWI251486B (en) 2006-03-21
BR0207829A (pt) 2004-06-22
CZ20032297A3 (cs) 2004-06-16
RS67503A (sr) 2006-12-15
US20020165272A1 (en) 2002-11-07
DK1401424T3 (da) 2007-02-26
US6541513B2 (en) 2003-04-01
MXPA03007722A (es) 2004-11-12
CA2439480C (en) 2011-04-26

Similar Documents

Publication Publication Date Title
RU2338537C2 (ru) СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
Baldessarini Drug therapy of depression and anxiety disorders
CA3225008A1 (en) Safer psychoactive compositions
JP2010531879A (ja) 水素化ピリド［４，３−ｂ］インドールに基づく抗不安作用を示す薬物、その薬理学的な化合物および適用方法
JP2010070573A (ja) ストレス関連障害を含む機能的身体障害の予防および処置
RS50676B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
RS67403A (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja
RS51056B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičkih poremećaja
RS51790B (sr) Upotreba derivata benzo-kondenzovanih heterocikličkih sulfamida za lečenje manije i bipolarnog poremećaja
US20050090488A1 (en) Drug combination for the treatment of depression and related disorders comprising mirtazapine
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
US20090275597A1 (en) Methods of treating cns disorders
US20120010125A1 (en) Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders
US20250302773A1 (en) Compositions comprising meai and n-acylethanolamines and uses thereof
RS50505B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja
EP3302493B1 (en) Inhibitors of cystine-glutamate transporter for use in treating or preventing substance-related and addictive disorders
WO2010126527A1 (en) Methods of treating cns disorders
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
RS4604A (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola u vezi sa klasterskim i migrenskim glavoboljama
Maan Comparison of Methamphetamine and MDMA Extended Access Self-administration: Acquisition, Maintenance, and Response Patterns
Al Mustafa et al. Assessment of Neuro-Behavioral Effects of Scopolamine in Male Mice